Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

13/02/2026 06:40

Feb 13 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            204.07              193.74           280.00    
                 (+5.3 pct)          (+15.1 pct)      (+7.9 pct)  
  Operating         19.49               18.61            27.00    
                 (+4.7 pct)          (+40.9 pct)      (+16.2 pct) 
  Recurring         23.99               21.76            25.30    
                 (+10.3 pct)         (+26.7 pct)      (-3.3 pct)  
  Net               17.08               14.62            17.70    
                 (+16.8 pct)         (+27.0 pct)      (-6.8 pct)  
  EPS            347.01 yen          297.10 yen       359.57 yen  
  Ann Div                             70.00 yen        80.00 yen  
  -Q2 div         40.00 yen           30.00 yen                   
  -Q4 div                             40.00 yen        40.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T